BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29981672)

  • 21. Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases.
    Ganti AK; Potti A; Koch M; Tendulkar K; Hanekom D; Koka V; Levitt R
    Med Oncol; 2002; 19(4):233-7. PubMed ID: 12512917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early onset pancreatic cancer: risk factors, presentation and outcome.
    Piciucchi M; Capurso G; Valente R; Larghi A; Archibugi L; Signoretti M; Stigliano S; Zerboni G; Barucca V; La Torre M; Cavallini M; Costamagna G; Marchetti P; Ziparo V; Delle Fave G
    Pancreatology; 2015; 15(2):151-5. PubMed ID: 25708929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States.
    Ordonez JE; Hester CA; Zhu H; Augustine M; Porembka MR; Wang SC; Yopp AC; Mansour JC; Zeh HJ; Polanco PM
    Ann Surg Oncol; 2020 Jun; 27(6):1997-2006. PubMed ID: 31894482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
    Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
    HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience.
    Krishna SG; Li F; Bhattacharya A; Ladha H; Porter K; Singh A; Ross WA; Bhutani MS; Lee JH
    Gastrointest Endosc; 2015 Feb; 81(2):370-9. PubMed ID: 25442085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
    Agarwal B; Krishna NB; Labundy JL; Safdar R; Akduman EI
    Gastrointest Endosc; 2008 Aug; 68(2):237-42; quiz 334, 335. PubMed ID: 18423464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study.
    Kimura H; Ohtsuka T; Matsunaga T; Watanabe Y; Tamura K; Ideno N; Aso T; Miyazaki T; Osoegawa T; Aishima S; Miyasaka Y; Ueda J; Ushijima Y; Igarashi H; Ito T; Takahata S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2015 Oct; 44(7):1148-54. PubMed ID: 26284536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    Sheikh M; Masoudi S; Bakhshandeh R; Moayyedkazemi A; Zamani F; Nikfam S; Mansouri M; Shishavan NG; Nikeghbalian S; Brennan P; Malekzadeh R; Pourshams A
    PLoS One; 2020; 15(12):e0243511. PubMed ID: 33275621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma.
    Salami A; Obaid T; Joshi ART
    Am J Surg; 2019 Jan; 217(1):103-107. PubMed ID: 29807632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.
    Sellam F; Harir N; Khaled MB; Mrabent NM; Salah R; Diaf M
    J Gastrointest Cancer; 2015 Jun; 46(2):126-30. PubMed ID: 25737417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma.
    McWilliams RR; Bamlet WR; Rabe KG; Olson JE; de Andrade M; Petersen GM
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1143-7. PubMed ID: 16861052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
    Hester CA; Augustine MM; Choti MA; Mansour JC; Minter RM; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Surg Oncol; 2018 Jul; 118(1):21-30. PubMed ID: 29878370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current diagnosis and treatment of pancreatic cancer].
    Heinrich S; Schäfer M; Bauerfeind P; Pestalozzi BC; Clavien PA
    Praxis (Bern 1994); 2005 Aug; 94(33):1243-54. PubMed ID: 16138769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
    Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
    Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.